Enteral feeding devices to gain significant demand in the near future due to increasing burden of chronic disease across developed countries

 


Enteral feeding devices technological advanced medical device used
to deliver nutrition food directly to the stomach to the bedridden patient
suffering from chronic diseases such as cancer and neurological disorder. 

 The increase in the cases of malnutrition and premature birth
cases around the globe is a prime factor driving growth of the enteral feeding
devices market. Moreover, the growing prevalence of chronic diseases such as
cancer and cardiovascular disease is another key factor fostering the market
growth of the enteral feeding devices. According to the World Health
Organization, cancer is the second leading cause of death globally and is
responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6
deaths occur due to cancer. Around 70% of deaths from cancer occur in low- and
middle-income countries. Furthermore, increasing global expenditure on the
healthcare sector for improving the patient care is further projected to
augment the growth of the enteral feeding devices market. 

 From the geographical perspective, North America is projected to
gain significant growth over the forecast period and this is attributed to the
high presence of the geriatric population prone to chronic disease that leads
to digestive ailments. According to the U.S. Census Bureau, there were 40.3
million U.S. residents 65 years and older in the 2010 Census and more than 54
million on July 1, 2019. Also, the rising number of surgical and minimally
invasive procedures in the region is further expected to accelerate the
regional market growth of the enteral feed device. According to the American
Society of Plastic Surgeons (ASPS) report, over 17.7 million cosmetic
procedures and minimally-invasive cosmetic procedures were performed in the
U.S. in 2018. 

 Key Developments:

1.      In October
2019, Fidmi Medical, a company based in Israel, won FDA clearance for its new
low-profile enteral feeding device. The product is manufactured to help overcome
many of the challenges presented by percutaneous endoscopic gastrostomy (PEG)
tubes, especially dislodgements and clogging of the inside.

2.      In March
2019, Medline expanded its enteral feeding portfolio with the launch of new
Blenderized Meals, Kitchen Blends. The new products complement Medline’s robust
portfolio of nutrient supplements and devices for tube feeders. 



















3.      In January
2017 Vygon, the single-use medical devices group announced the launch of
easymoov6, a more intuitive enteral feeding pump. The device is connected via a
tube to a nutrient bag and equipped with a digital interface, the pump supports
the management of enteral feeding in both hospital and home care.

Comments

Post a Comment

Popular posts from this blog

The Global Gynecological Devices Market Continues To Grow Owing To The Rising Demand For Regular Gynecological Checkups And Increasing Awareness On Women’s Health And Hygiene

Image
  A gynecological device is a medical device that is used to promote female health or to protect and preserve reproductive health for females. This is a very broad category and includes products such as watches, calculators, bandages, and hygienic towels. While many of these products have been clinically tested and found to be safe for female health, there are still a few devices in the market that pose threats to female reproductive health. Gynecological devices are usually fall into three categories: medical devices, biological safety devices, and mechanical devices. Medical devices are those that prevent the risk of injury or trauma to a woman's reproductive organs from medical interventions. Biologic safety devices are those that protect a female's health by promoting female reproductive health. Finally, mechanical devices are those that help maintain a woman's reproductive health and allow her to achieve or reach their desired fertility or pregnancy. The use of any of ...
Read more

Polyethylene Terephthalate Market Continues to Expand as British Petroleum plc signs a cooperation agreement with China Resources Chemical Materials Technology Co. Ltd to strengthen cooperation on PTA sourcing

Image
  PET is an abbreviation for polyethylene terephthalate; the material most often used in PET bottles. PET is an extremely tough plastic, which is why it's commonly used as a packaging material. PET has many advantages over other plastics, including strength, resistance to breaking and crushing, and its natural plasticity it will fill almost anything and is resistant to oil and chemicals that can cause it to break down over time. Rapid growth of the food and beverage industry is expected to drive of the global polyethylene terephthalate market growth . The food and beverage industry has witnessed significant growth in both developed and emerging economies. According to the Food and Drink Federation, the U.K., the food and drink manufacturing sector accounts for 17% in terms of economic contribution. Furthermore, according to the India Brand Equity Foundation (IBEF), the food processing industry contributed 14% of the country’s GDP in 2016. Polyethylene terephthalate or PET is widely...
Read more

Stomach Cancer Drugs Market Continues to Expand as South Korean Drug Manufacturer Celltrion Inc. Receives the WHO Prequalification Standards for its biosimilar

Image
  Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world.  Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning. Increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600...
Read more